<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK'S Final 2017 Spinal Cord Stimulation Market Financial Results

Posted by Anne Staylor on 4/9/18 12:27 PM

Blog Post Social Media -Spinal Cord Stim 2017The US Spinal Cord Stimulation market reached new heights in Q417/FY17, driven by new products, expanding indications, and a growing demand for non-narcotic alternatives for treating chronic intractable pain. 

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 US Spinal Cord Stimulation Market Recap and Financial Dashboard.

Among the many topics covered in the Q417/FY17 Spinal Cord Stimulation Market Recap are:

  • Annual Opioid Rx Trends
  • 2017 Market Shares
  • Competitive Surprises
  • Nevro: Slow and Steady Gains
  • Boston Scientific: Regaining Momentum
  • Medtronic: Intellis Leads Turnaround

The US SCS market saw phenomenal growth in 2017, reaching revenues of ...

Read the entire Spinal Cord Stim Market Recap including new, data and analysis*

*This article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.

Request SmartTRAK Spinal Cord Stim Market Subscription Info

Topics: Neuromodulation-Spinal Cord Stimulation

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts